Tuesday, 7 February 2023 to Wednesday, 8 February 2023

Speakers

Dr Andrew Bassett
Wellcome Sanger Institute
Dr Paul Blainey
Broad Institute of MIT and Harvard and MIT Department of Biological Engineering
United States
Dr André Cohnen
Bayer AG
Germany
Dr Klaas de Lint
Amsterdam University Medical Center
Netherlands
Prof Bart De Strooper
UK DRI
Dr Michael Deans
Yale University
United States
Dr Dzana Dervovic
AstraZeneca
Sweden
Dr Charlie Dunlop
AstraZeneca
Dr Traver Hart
The University of Texas MD Anderson Cancer Center
United States
Dr Kevin Holden
Synthego
United States
Mr Stewart Humble
NINDS & University of Oxford
Dr Mark J. Graham
Beckman Coulter UK Ltd.
Mrs Ashley Jacobi
Integrated DNA Technologies - Coralville, IA
United States
Prof Robert Manguso
Massachusetts General Hospital Cancer Center
United States
Dr Klio Maratou
GSK
Dr Marcello Maresca
AstraZeneca
Sweden
Dr Libby Naylor
GenScript Biotech
Dr Sofia Pavlou
AstraZeneca
Vendor Presentations
ELRIG
Dr Radu Rapiteanu
GSK
Dr Paula Rio
CIEMAT
Spain
Dr Foad Rouhani
Kings College Hospital
Dr Aurore Saudemont
GlaxoSmithKline
Dr Henrik Schmidt
Myllia Biotechnology GmbH
Austria
Ms Geraldine Servant
Charles River Laboratories
Netherlands
Dr Greg Sienski
AstraZeneca
Sweden
Dr Hong Kee Tan
Wellcome Sanger Institute
Prof Fyodor Urnov
UC, Berkeley
Dr David Walter
Cancer Research Horizons
Prof Jonathan Weisssman
Whitehead Institute
United States
Dr Jonathan Whitchurch
iotaSciences